Skip to main content
Cureus logoLink to Cureus
. 2023 Jan 12;15(1):e33725. doi: 10.7759/cureus.33725

Fetus-in-Fetu: A Differential Diagnosis of Neonatal Fetiform Encysted Abdominal Mass

Muhammad C Jihwaprani 1, Ahmed A Mousa 1, Ali A Mohamed 2, Yousef Alkouz 3,✉, Inas H Bahlawan 4
Editors: Alexander Muacevic, John R Adler
PMCID: PMC9925022  PMID: 36793819

Abstract

Fetus-in-fetu (FIF) is a rare embryological anomaly in which an encysted fetiform mass develops within the infant or adult host body. It mainly occurs intraabdominal. There are embryo-pathogenetic debates over whether it belongs to the spectrum of highly differentiated teratomas or is a parasitic twinning from a monozygotic monochorionic diamniotic pregnancy. The presence of vertebral segments and an encapsulating cyst can reliably distinguish FIF from teratoma. The diagnosis may be initially made by imaging modalities such as computed tomography (CT) and magnetic resonance imaging (MRI), and a confirmatory diagnosis made by histopathology of the excised mass. Our center experienced a case of a male neonate presented after emergency cesarean delivery at 40-week gestation with the suspicion of an intraabdominal mass identified antenatally. Antenatal ultrasonography at 34 weeks gestation suggested the presence of an intraabdominal cystic mass measuring 6.5 cm with a hyperechoic focus. A follow-up MRI performed after the delivery showed a well-defined mass with the cystic formation in the left abdominal region with a centrally located fetiform structure. Vertebral bodies and long limb bones were visualized. The diagnosis of FIF was initially made preoperatively by the characteristic findings of imaging studies. Laparotomy was scheduled on day 6, revealing a large encysted mass with fetiform content. FIF should be considered a possible differential diagnosis of neonatal encysted fetiform mass. Routine antenatal imaging permits more frequent antenatal detection with earlier workup and management.

Keywords: antenatal diagnosis, twinning, neonatal mass, teratoma, fetus-in-fetu

Introduction

Fetus-in-fetu (FIF) is an extremely rare congenital anomaly in which a vertebrate fetus-like mass is situated within the body of its fully developed host. Two main hypotheses on the pathogenesis of FIF have been described. The "included-twin" or "parasitic-twin" theory suggests that FIF arises from an anomalous monozygotic monochorionic diamniotic twin pregnancy. The malformed fetus becomes entrapped within its twin while dependent on its blood supply via persistent anastomosis of vitelline circulation [1,2]. Alternative theory, the "teratoma-spectrum" theory, suggests that FIF arises as a highly differentiated mature fetiform teratoma. Teratoma is a type of germ cell neoplasm consisting of at least two of three germ layers, i.e. endoderm, mesoderm, and ectoderm. FIF usually presents as a localized swelling that may compress adjacent structures due to the growing mass effect. Diagnosis can be provisionally made by imaging studies such as plain radiography, ultrasonography, computed tomography (CT), and magnetic resonance imaging (MRI), which are confirmed by exploratory laparotomy and complete surgical excision of the mass.

Case presentation

A full-term male neonate born to a 21-year-old primigravida presented with a swelling in the left abdomen. The baby was previously delivered via emergency cesarean section due to prolonged labor at 40 weeks gestation. Apgar's score was 9 both at 1 and 5 minutes. His birth weight was 3500 grams. The mother did not have any significant previous history of medical illness before and during pregnancy. There was no history of radiation exposure. She was not a smoker. There was no medication history apart from the prescribed antenatal supplements.

During the antenatal period, the mother underwent antenatal ultrasonography (USG) at 29+3-week gestation, which suggested the presence of a congenital anomaly. The USG showed an intraabdominal mass in a single viable developing fetus with a cephalic presentation. The estimated weight of the fetus was 1413 grams and the amniotic fluid level (AFL) was 4.3 centimeters at the largest sack. A follow-up USG was scheduled at 34 weeks of gestation, demonstrating an intra-abdominal cystic mass of unknown origin measuring 6.5 centimeters and a hyperechoic focus measuring 4.5 centimeters. The mass pushed the left kidney anteriorly and medially, resulting in left renal pelvic dilatation. The estimated fetal weight was 2745 grams in cephalic presentation with an AFL of 6.3 centimeters.

The complete neonatal examination was remarkable for a distended abdomen with a palpable midline abdominal mass. Laboratory investigation revealed serum α-fetoprotein (AFP) of 3000 nanograms/milliliter (normal: 0-5.8 nanogram/milliliter) and β-human chorionic gonadotropin of 3.16 mIU/liter (normal: 0-5.3 mIU/liter). All other values including complete blood count, urea, electrolytes, and liver function tests were within normal ranges. A plain baby-gram X-Ray (Figure 1) demonstrated a midline abdominal mass with multiple ectopic calcified structures indicating bones. Abdominal USG (Figure 2) revealed a well-defined cystic structure in the center of the abdomen to the left side measuring around 80 x 50 millimeters with heterogenous soft tissue content, which is highly suggestive of a non-viable fetus inside a cyst, with an empty skull, vertebrae, and limbs. Correspondingly, the MRI showed a well-defined cystic mass in the left abdomen anterior to the left kidney with a centrally located fetus (Figure 3 A and B). Multiple long-shaped hyperintensities that correspond to fetal limbs were also observed. Vertebral bodies were visualized on axial T1-weighted MRI which indicates spina bifida. The mass compresses and displaces the bowel loop anteriorly and to the right side (Figure 3 B). The head was not visualized well with a well-defined cystic structure abutting the cervical spine may be due to hydrocephaly or myelomeningocele. Those findings were consistent with a malformed fetus located in the body of its twin, suggesting the diagnosis of FIF.

Figure 1. Plain baby-gram X-Ray showing multiple calcifications in the left abdominal area at the level of the L1-L4 vertebrae adjacent to the midline (yellow arrows).

Figure 1

Figure 2. Abdominopelvic USG of the newborn demonstrating a well-defined cystic structure seen in the center of the abdomen to the left side measuring about 80 x 50 millimeters with heterogeneous soft tissues content which is highly suggestive of a nonviable fetus (blue arrow) seen inside the cyst (yellow arrow). Empty skull with vertebral organization and limb buds formation were also visualized.

Figure 2

USG: ultrasonography

Figure 3. MRI of the patient showing a well-defined cystic mass in the left abdominal region anterior to the left kidney (A and B, yellow arrow) with a centrally located fetiform structure (B, blue arrow). The mass compresses and displaces the bowel loops anteriorly and to the right side (B, green arrow).

Figure 3

MRI: magnetic resonance imaging

Exploratory laparotomy was scheduled at the age of six days with a left upper abdominal incision, revealing a large encysted mass (Figure 4 A). The cyst was mobilized from the left colon, left renal vein, and left ureter, and is excised completely. Dissection of the cyst revealed fetus-like structures (Figure 4 B and C) with limb buds visible and anencephalic features. The postoperative period at the neonatal intensive care unit was uneventful, and the baby was discharged at the age of nine days old. A subsequent follow-up visit at six months showed a normally developing infant with no recurrence of the soft tissue mass at the site of surgery. Measurement of serum AFP also demonstrated a regression compared to the preoperative level, measuring around 39 nanograms/milliliter.

Figure 4. Exploratory laparotomy with excision of the mass revealing a large encysted mass (A). Excision of the cyst showed a fetus-like structure (B and C) with protruding limb buds and anencephalic features.

Figure 4

Discussion

FIF is a rare developmental anomaly with a prevalence of less than one in 500,000 births. It has a slight male preponderance (2 male: 1 female) [3]. Despite the two pathogenetic controversies on whether FIF represents a distinct pathogenetic entity (the parasitic-twin theory) or is a part of the fetiform teratoma spectrum (the teratoma-spectrum theory), distinguishing FIF from teratoma is extremely important. That is because even mature cystic teratoma carries a risk of malignancy from 3.5% to as high as 6.67%, while immature teratoma should be regarded as malignant [4,5]. In contrast, there were only two known cases of malignant recurrences in the case of FIF [6,7]. The fetiform mass in FIF is genetically identical to its host body and is usually single, although the case of multiple FIF masses in a single host has also been reported [8]. The differences between FIF and teratoma are summarized in (Table 1).

Table 1. Comparison between FIF and teratoma.

FIF: fetus-in-fetu

  Fetus-in-fetu Teratoma
Definition Congenital anomaly in which a vertebrate fetus-like mass is entrapped within the body of its fully developed host Germ cell neoplasm due to disorganized pluripotent cell proliferation, contents are derived off of >2/3 germ layers
Common sites Abdominal, retroperitoneal Ovaries, testes
Size Variable, usually 5-8 centimeters3 Usually large (>6 centimeters3)
Cyst surrounding the fetiform mass Yes No
Vascular pedicle Connected to the host by a small number of relatively large vascular pedicles No vascular pedicle. Usually has a wider attachment site with multiple small blood vessels.
Anatomical structures Grossly recognizable, well-formed. Mostly acardiac and anencephalic Occasional, disorganized. E.g. cartilage, hair, respiratory mucosa, teeth, and intestinal mucosa.
Axial skeletal segments Its presence is pathognomonic Not present
Risk of malignant change/recurrence Extremely low Immature: High if left untreated Mature: 3.5-6.67%
Staging of the tumor Not required Required
α-fetoprotein level Elevated (typically >3000 nanogram/milliliter) Not elevated
Management Surgical excision is curative. An early operation is needed if the mass effect compromises organ functions. Early surgical excision (risk of malignant transformation if delayed)

Most cases of FIF occur retroperitoneally in the abdominal region (80%). This may be explained by the fact that vitelline circulation embryologically develops into the superior mesenteric artery that is located retroperitoneally. However, its occurrence in other areas has also been reported, including intracranial [9], intrahepatic [10], intrathoracic [11], oral cavity [12], sacrococcygeal [13], and undescended testis [14].

The diagnostic findings favoring FIF over teratoma include the presence of axial skeleton and limb buds on imaging modalities. Willis et al. regarded the presence of a vertebral column as one of the important diagnostic criteria of FIF [15]. The presence of vertebrae indicates an organized embryological development that has developed notochord, the precursor of vertebral bones, during the primitive streak stage. In contrast, teratomata develop as a result of disorganized and uncontrolled pluripotent cell replication, thus vertebral segmentation and organogenesis are not usually found [1,16]. In the neonate, other differential diagnoses should include meconium pseudocyst, which is the result of meconium peritonitis caused by prenatal bowel perforation. In females of reproductive age, ectopic pregnancy should also be considered as a potential differential diagnosis of the fetiform mass [17].

Spencer et al. have proposed that the diagnosis of FIF requires at least one of the following conditions met [2]: (1) it is enclosed within a distinct cyst; (2) it is partially or entirely covered in normal skin; (3) it has anatomical structures that are grossly recognizable; (4) it is connected to the host by a small number of relatively large blood vessels; and (5) it is either positioned immediately next to one of the sites where conjoined twins attached, or be connected to the neural tube or the gastrointestinal system.

Antenatal diagnosis of FIF is made possible by the advancement in imaging modalities. A plain radiograph can sufficiently secure the tentative diagnosis of FIF when the vertebral column and long limb bones are visualized. USG may visualize the fetiform mass and delineate the presence of a cyst enclosing it. More advanced imaging modalities such as CT and MRI can further aid in the diagnosis. In addition to the identification of long bones and vertebral segments, they can establish the exact relationship with the surrounding structures and the mass effect it has caused, e.g. compression and displacement. Laboratory investigations typically reveal an elevated AFP, typically ≥3000 nanograms/milliliter, further supporting the diagnosis of FIF [18]. Consequently, postoperative follow-up for FIF should include the serial measurement of AFP, showing a significant decrease after complete excision of the fetiform mass [19].

Conclusions

In conclusion, FIF should be considered as a differential diagnosis in a neonate presenting with an encysted fetiform mass. Early diagnosis is made more frequently nowadays due to antenatal routine imaging such as USG. Further imaging modalities such as CT or MRI can reliably differentiate FIF from teratoma by the presence of the encapsulating cyst, vertebral organization, and limb bones in the fetiform mass. The condition should also be differentiated from ectopic pregnancy in adult females and meconium pseudocyst in neonates. Despite its benign nature, post-operative follow-up with serum AFP and imaging modalities may be necessary.

The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.

The authors have declared that no competing interests exist.

Human Ethics

Consent was obtained or waived by all participants in this study

References

  • 1.Fetus in fetu or fetiform teratoma? Report of two cases. Faizi FR, Rasouly N, Aien MT. J Pediatr Surg Case Rep. 2020;61:101605. [Google Scholar]
  • 2.Parasitic conjoined twins: external, internal (fetuses in fetu and teratomas), and detached (acardiacs) Spencer R. Clin Anat. 2001;14:428–444. doi: 10.1002/ca.1079. [DOI] [PubMed] [Google Scholar]
  • 3.Foetus-in-foetu. Grant P, Pearn JH. Med J Aust. 1969;1:1016–1019. doi: 10.5694/j.1326-5377.1969.tb49866.x. [DOI] [PubMed] [Google Scholar]
  • 4.Malignant transformation in mature cystic teratoma of the ovary: a retrospective study of eight cases and review of literature. Rathore R, Sharma S, Agarwal S. Prz Menopauzalny. 2018;17:63–68. doi: 10.5114/pm.2018.77304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Coleman R, Westin SN, Ramirez PT, Salvo G, Gershenson DM. Comprehensive Gynecology. Elsevier; 2021. Malignant Diseases of the Ovary, Fallopian Tube, and Peritoneum; pp. 707–753. [Google Scholar]
  • 6.Fetus-in-fetu with malignant recurrence. Hopkins KL, Dickson PK, Ball TI, Ricketts RR, O'Shea PA, Abramowsky CR. J Pediatr Surg. 1997;32:1476–1479. doi: 10.1016/s0022-3468(97)90567-4. [DOI] [PubMed] [Google Scholar]
  • 7.Malignant transformation of a well-organized sacrococcygeal fetiform teratoma in a newborn male. Chen YH, Chang CH, Chen KC, Diau GY, Loh IW, Chu CC. J Formos Med Assoc. 2007;106:400–402. doi: 10.1016/S0929-6646(09)60326-0. [DOI] [PubMed] [Google Scholar]
  • 8.Fetus in fetu: review of the literature over the past 15 years. Prescher LM, Butler WJ, Vachon TA, Henry MC, Latendresse T, Ignacio Jr RC. J Pediatr Surg Case Rep. 2015;3:554–562. [Google Scholar]
  • 9.Fetus in fetu: a medical curiosity - considerations based upon an intracranially located case. Maryńczak L, Adamek D, Drabik G, Kwiatkowski S, Herman-Sucharska I, Lankosz-Lauterbach J. Childs Nerv Syst. 2014;30:357–360. doi: 10.1007/s00381-013-2191-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Intrahepatic fetus-in-fetu: a case report and review of the literature. Magnus KG, Millar AJ, Sinclair-Smith CC, Rode H. J Pediatr Surg. 1999;34:1861–1864. doi: 10.1016/s0022-3468(99)90333-0. [DOI] [PubMed] [Google Scholar]
  • 11.Thoracic fetus in fetu. Reddy RK, Kannaiyan L, Srirampur S, Malleboyina R, Irfan GM, Sharab H, Kannepalli S. J Indian Assoc Pediatr Surg. 2012;17:178–179. doi: 10.4103/0971-9261.102344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Oral fetus-in-fetu: a case report. Abdulraheem NT, Nasir AA, Abdur-Rahman LO, et al. J Pediatr Surg Case Rep. 2015;3:171–173. [Google Scholar]
  • 13.A rare case of fetus in fetu in the sacrococcygeal region: CT and MRI findings. Lu T, Ma J, Yang X. BMC Pediatr. 2021;21:575. doi: 10.1186/s12887-021-03063-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Fetus in fetu associated with an undescended testis. Alpers CE, Harrison MR. Pediatr Pathol. 1985;4:37–46. doi: 10.3109/15513818509025901. [DOI] [PubMed] [Google Scholar]
  • 15.Willis RA. Bull N Y Acad Med. Vol. 26. London: Butterworths and Co; 1950. The borderland of embryology and pathology; pp. 440–460. [PMC free article] [PubMed] [Google Scholar]
  • 16.A review of the mechanisms and evidence for typical and atypical twinning. McNamara HC, Kane SC, Craig JM, Short RV, Umstad MP. Am J Obstet Gynecol. 2016;214:172–191. doi: 10.1016/j.ajog.2015.10.930. [DOI] [PubMed] [Google Scholar]
  • 17.Fetus in fetu: case report and brief review of literature on embryologic origin, clinical presentation, imaging and differential diagnosis. Sitharama SA, Jindal B, Vuriti MK, Naredi BK, Krishnamurthy S, Subramania DB. Pol J Radiol. 2017;82:46–49. doi: 10.12659/PJR.899956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Rare fetus-in-fetu: experience from a large tertiary pediatric referral center. Xiaowen M, Lingxi C, Song L, Shengbao P, Xiaohong Y, Xinghai Y. Front Pediatr. 2021;9:678479. doi: 10.3389/fped.2021.678479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Fetus-in-fetu or well-differentiated teratoma - a continued controversy. Mohta A, Khurana N. Indian J Surg. 2011;73:372–374. doi: 10.1007/s12262-011-0251-4. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cureus are provided here courtesy of Cureus Inc.

RESOURCES